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Abstract
Background: Food insecurity is emerging as an important barrier to antiretroviral (ARV) adherence in sub-Saharan Africa
and elsewhere, but little is known about the mechanisms through which food insecurity leads to ARV non-adherence and
treatment interruptions.
Methodology: We conducted in-depth, open-ended interviews with 47 individuals (30 women, 17 men) living with HIV/
AIDS recruited from AIDS treatment programs in Mbarara and Kampala, Uganda to understand how food insecurity
interferes with ARV therapy regimens. Interviews were transcribed, coded for key themes, and analyzed using grounded
theory.
Findings: Food insecurity was common and an important barrier to accessing medical care and ARV adherence. Five
mechanisms emerged for how food insecurity can contribute to ARV non-adherence and treatment interruptions or to
postponing ARV initiation: 1) ARVs increased appetite and led to intolerable hunger in the absence of food; 2) Side effects of
ARVs were exacerbated in the absence of food; 3) Participants believed they should skip doses or not start on ARVs at all if
they could not afford the added nutritional burden; 4) Competing demands between costs of food and medical expenses
led people either to default from treatment, or to give up food and wages to get medications; 5) While working for food for
long days in the fields, participants sometimes forgot medication doses. Despite these obstacles, many participants still
reported high ARV adherence and exceptional motivation to continue therapy.
Conclusions: While reports from sub-Saharan Africa show excellent adherence to ARVs, concerns remain that these
successes are not sustainable in the presence of widespread poverty and food insecurity. We provide further evidence on
how food insecurity can compromise sustained ARV therapy in a resource-limited setting. Addressing food insecurity as part
of emerging ARV treatment programs is critical for their long-term success.
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Introduction
Non-adherence to antiretroviral (ARV) therapy is one of the most
important predictors of incomplete HIV RNA suppression, immuno-
logic decline, progression to AIDS and death [1,2,3,4,5,6]. ARV non-
adherence creates particular challenges in resource-limited settings.
Stopping ARV therapy for two or more weeks can lead to drug-
resistant virus and negate the clinical benefit of the only medications
currently available in settings with few treatment options.
When highly active antiretroviral therapy (HAART) was first
introduced in sub-Saharan Africa a decade ago, the medications
were generally sold to patients at prohibitive prices. These
expenses were among the most significant barriers to ARV
treatment adherence [7,8,9,10,11]. In recent years, internation-
al aid programs, such as the Global Fund to Fight AIDS,
Tuberculosis, and Malaria and the U.S. government’s Presi-
dent’s Plan for Emergency AIDS Relief (PEPFAR), have
substantially expanded support for programs that provide
ARV medications free of charge in sub-Saharan Africa and
elsewhere. While these efforts have led to improvements in
treatment retention and adherence [12], they have not
eliminated all socio-economic and structural barriers to
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accessing treatment and sustaining a long-term medication
regimen. [13,14,15].
Food insecurity, defined as ‘‘the limited or uncertain availability
of nutritionally adequate, safe foods or the inability to acquire
personally acceptable foods in socially acceptable ways’’ [16], has
recently been identified as a key structural barrier to ARV
adherence and as a contributor to ARV treatment interruptions in
resource-poor settings [13,17,18,19,20]. In a qualitative study
from Uganda, Tanzania, and Malawi, hunger during HAART
initiation emerged as a leading obstacle to ARV adherence [13].
In a study in Northeastern Uganda, consuming only one meal per
day and being dependent on caregivers for food were risk factors
for ARV non-adherence [21]. In Zambia, the belief that ARVs
must be taken with food led individuals to skip doses when they
could not access enough to eat [18]. Lack of food was also among
the key barriers to ARV adherence in a qualitative study from
South Africa [20].
Uganda has a high prevalence of both food insecurity and HIV/
AIDS and is an appropriate environment to explore the overlap
between these two epidemics. In Uganda, AIDS is responsible for
up to 12% of annual deaths and has surpassed malaria and other
conditions as the leading cause of mortality among individuals
between the ages of 15 and 49 [22]. Food insecurity is also
widespread. In a study among PLWA living in urban areas in
Uganda, 95% of households reported that they sometimes or often
had to eat less preferred foods, 62% reported that sometimes or
often all household members had to skip meals, and 22% reported
that sometimes or often all household members did not eat for an
entire day [23].
While the World Health Organization, UNAIDS, and the
World Food Program have recommended integration of food
assistance into HIV AIDS programming, [24,25,26,27,28] there
has been little research on the mechanisms through which food
insecurity may lead to gaps in treatment and compromise ARV
effectiveness. Understanding such mechanisms is important for
designing ARV treatment programs that incorporate food or
nutritional supplementation and guiding policy decisions about
intervention strategies. The prior qualitative studies that identified
links between food insecurity and ARV non-adherence were
designed to examine barriers to ARV adherence in general, and
did not investigate in depth the multi-faceted relationship between
food insecurity and non-adherence. We undertook a qualitative
study in Uganda to understand and contextualize the role of food
insecurity in the lives of HIV-infected patients and to investigate
the pathways and mechanisms through which food insecurity
could lead to missed doses and treatment interruptions.
Methods
In August and September of 2007, we conducted semi-
structured interviews with 47 women and men living with HIV/
AIDS. Forty-one of the participants—29 women and 18 men–
were selected from among those arriving each weekday morning to
pick up their monthly supply of ARVs or to attend to other health
care needs at the Immune Suppression Clinic at the Mbarara
University of Science and Technology in Mbarara, Uganda, a
trading center for the country’s southwest region. The remaining
six were selected from patients on early self-pay ARV therapy
from the Adherence Monitoring Ugandan Cohort Study in
Kampala, Uganda.
Participants were eligible for inclusion in the study if they were
HIV-infected adults 18 years or older receiving HIV care at one of
the study sites. We sampled using an inductive and iterative
approach, while seeking to capture diverse perspectives and
characteristics. We aimed to interview both women and men, and
individuals on both free and self-pay ARVs, as well as some who
had not yet initiated ARV therapy, in order to study barriers to
ARV initiation. We also sought participants from both urban and
rural settings. Sample size was determined by theoretical
saturation, the point at which new categories and dimensions no
longer emerged from interviews. Clinic staff familiar with the
histories of many attendees helped to identify and recruit potential
participants in the study. Written informed consent was obtained
from all participants by an experienced local interpreter, who was
also a trained interviewer. All interviews were conducted in a
private location at the clinic. Patients who agreed to participate in
the study were compensated for their time with reimbursement for
transportation costs to and from the clinic. All study procedures
were approved by the Committee on Human Research at the
University of California, San Francisco, the Mbarara University of
Science and Technology (MUST) Institutional Review Board
(Mbarara, Uganda), the Makarere University Faculty of Medicine
and the Uganda National Council for Science and Technology
(Kampala, Uganda).
Data collection
Most interviews from Mbarara were conducted in English and
Runyankole, and those from Kampala in English and Luganda,
the key languages spoken in the respective regions. One of the
study investigators conducted most interviews in conjunction with
a trained interviewer and interpreter. Interviews lasted from
30 minutes to 2 hours.
The interview guide included semi-structured and open-ended
questions, followed by probes based on initial responses. This
approach ensured that specific topics were covered in each
interview, but also allowed for the emergence of new and
unexpected themes. Our probes were designed to elicit detailed
descriptions of participants’ opinions, behaviors, and survival
strategies in the domains of food security and ARV adherence. All
participants were asked about their overall food situation, how
often they were hungry, and where and how they found food to
feed themselves and their families. If they were already taking
ARVs, they were asked about general barriers to ARV adherence,
and more specifically whether their food situation impacted their
ability to take their medications as prescribed. Where relevant,
participants were asked to describe in detail the ways in which
food insecurity might pose a barrier to ARV adherence. For
participants not yet on ARVs, we investigated the reasons that
they had not yet initiated HAART, including any reasons related
to food, and key barriers to initiating ARV treatment in the future.
Data Analysis
Interviews were digitally recorded, translated into English, and
transcribed verbatim. The study interviewer maintained field notes
on contextual details and impressions that were not captured in
the interview transcripts. We analyzed the data by relying on the
strategy of grounded theory using open and axial coding [29]. This
process involved reviewing, comparing, labeling, and categorizing
the data, and then drawing connections between categories
according to a coding strategy that involved conditions, context,
interactions and consequences. Two of the study investigators
conducted an initial review of the interviews and identified
repeated observations in the data, collating those into major
themes and related sub-themes. Themes and subthemes were
revised and refined by successive returns to the data. Peer
debriefing was conducted to ensure trustworthiness of the data and
to assist in refining the coding strategy.
Food Insecurity and Adherence
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Results
The participants ranged in age from 24 to 59 years, with a
median age of 37 for the women and 40 for the men. Of the
Mbarara participants, 23 were from rural areas, 12 from peri-
urban areas, and six from urban areas. Of the Kampala
participants, five were from urban areas and one was from a
peri-urban area. Small-scale farming, which many refer to as
‘gardening,’ was the most frequent occupation, although many
also reported earning income from selling food, clothes, and other
basic goods. Thirty-six reported being on a HAART regimen for
time periods ranging from one month to several years. Eleven had
not yet initiated HAART.
Food insecurity among participants
Food insecurity was common among participants, whether or
not they reported full adherence to their ARV regimens. All but
two reported having to struggle to find enough food to feed
themselves and their families. Women and men both experienced
significant food insecurity, but men were at times favored in terms
of food distribution within the household. As explained by one
HIV-positive widow: ‘‘Before you get married, your parents tell
you that you’re supposed to feed your husband, that he must eat
more food. So when I got to my husband’s home, whether I was
sick or anything, he must have more food according to what I was
told.’’ Women were also more likely than male respondents to
report being separated or widowed, which often reduced their
access to food. This was especially the case if they were the sole or
primary provider not only for themselves but for children, aging
parents, ailing siblings, orphaned nieces and nephews, and other
relatives impacted by AIDS. Women who remained with their
husbands or partners sometimes reported that fear of loss of access
to food for themselves and their children constrained their
freedom of action.
Both men and women reported that they could often only
afford to eat once or twice a day. Not surprisingly, food insecurity
was associated with persistent or intermittent hunger. According
to a widowed mother of four, hunger is ‘‘almost a daily
occurrence for me, I wake up and eat leftovers from last night,
and then I’ll go work in someone’s garden. But that person won’t
give me lunch, and I’m supposed to work there the whole day.’’
Her experience, she added, was common in her rural district:
‘‘There are 50 families in my village; only five can afford to have
food all the time, so the rest are looking for food from those
families.’’
Even many of those with plots of land for gardening reported
that they could not plant and harvest enough to avoid hunger.
Both men and women reported that they would feed their children
before taking food themselves when food was scarce. A 57-year-old
woman, who was responsible for feeding three grandchildren as
well as her two youngest children, explained: ‘‘I eat less food so my
children can eat, because their lives are ahead of them, and mine is
about to end, and they feel the privation of hunger more than I do.
So I eat less.’’
In addition to not having enough to eat, many participants
reported being able to access only poor quality food and a limited
selection of items. According to a 30-year-old widow who sold
goods door-to-door:
I eat matoke, beans, sweet potato, and posho. Sometimes I
like it, but most of the time, I feel like I should change what
I’m eating, but I can’t afford to…. from Monday to Friday
we’re eating the same thing all the time. That’s all we have.
Many participants described eating fish, poultry, and beef only a
few times a year, at most. They also reported that poor quality
diets and hunger compromised their physical and mental well-
being. As stated by a 44-year-old woman with no work: ‘‘If I could
eat what I’d like to eat, I wouldn’t be on edge all the time about
my life.’’
Food insecurity and ARV adherence
While many participants were motivated to take their ARV
medications as prescribed, 14 out of the 36 patients on ARVs
acknowledged that they had missed doses. Food insecurity
emerged as one of the most significant barriers to antiretroviral
adherence. This was the case both for participants who had missed
doses as well as for some who had so far managed to stay adherent
but were concerned about their ability to sustain high levels of
adherence in the future in the face of significant food insecurity.
The impact of food insecurity on adherence was particularly
salient among women in our sample. As stated by a 42-year-old
woman who reported severe stomach pain if she took her ARVs
without food: ‘‘In a week when I missed, that is when I have not
gotten food to eat. What happens sometimes I have to force myself
to take the medicine, but other times I cannot force myself to take
the medicine, so I just leave it.’’ A widow whose husband died of
AIDS and who began treatment in 2005 said that she skipped
some doses altogether and delayed other doses when she couldn’t
find enough food:
The most difficult or painful thing that I find about taking
my medicine is when the time for taking medicine
approaches and I don’t have something to eat. If I don’t
have something to eat, then I don’t take my medicine until I
have what to eat.
In some instances, participants suggested that ARV adherence
could lead to greater food security because of improved health
and ability to work; conversely, ARV non-adherence, by causing
a decline in health, could lead to greater difficulties in accessing
food. An older woman who had started ARVs two years
previously explained how the treatment had helped her in her
struggle for provisions: ‘‘These days it’s much easier to do the
gardening. Before I started my treatment, I was really, really sick,
but since I started I’m much stronger, I can carry stuff around,
I can go to garden and weed, and I am able to do much
more.’’
During the interviews, five mechanisms emerged through which
food insecurity undermined ARV adherence among both men and
women as well as impacted decisions about ARV treatment
initiation: 1) ARVs often increased appetite, and food scarcities
exacerbated the resulting hunger; 2) Side effects of ARVs were
reported to be much worse in the absence of food; 3) Participants
were counseled on the importance of taking ARVs with a balanced
diet and reported that some people did not start ARVs because
they could not afford the accompanying food; 4) Competing
demands between the cost of obtaining food and the cost of
medical treatment and transportation for monthly clinic visits led
people either to default from treatment, or to give up food and
wages to get medications; and 5) Long days of farming in the fields
or doing other work to earn money for food sometimes caused
people to skip or forget to take their doses. These varied
mechanisms led to missed doses and reports of delays in treatment
initiation as well as early treatment discontinuation. We also
explored the role of food supplementation on food insecurity and
adherence.
Food Insecurity and Adherence
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1. Increased appetite with ART
In many cases, participants reported that ARVs significantly
increased their appetite, which caused difficulties for those already
struggling to feed themselves and their families. As stated by a 44-
year old widow and mother of four: ‘‘Sometimes [after taking
ARVs] I am so hungry, it just comes and it’s intense, my whole
body is shivering from hunger.’’ According to a 26-year-old
woman with two children:
The ARVs made me hungrier…like you want to eat all the
time, even sometimes you feel that before you take them,
there should be something to eat. And two hours after taking
ARVs, you’re very hungry and feel like taking something.
A widow with six children compared the intense hunger associated
with taking ARVs to that of pregnancy: ‘‘It’s like when you’re
pregnant, you crave a lot of things. But even when you crave
things, you can’t have them.’’
Many participants reported living meal-to-meal rather than
having the resources to afford to keep much food at home. They
often had developed carefully calibrated eating strategies to make
food supplies last. The additional hunger associated with taking
ARVs threatened to disrupt the fragile stability of these strategies.
A 35-year-old mother of three, whose husband died of AIDS in
2001, explained:
Sometimes when we swallow this medicine we feel like
eating all the time. So you eat and feel satisfied but in a few
minutes, you feel hungry and you want to eat again, and yet
you can have prepared very little food that you have eaten
and finished…maybe a few fingers of matoke, a quarter
kilogram of rice, and therefore you just stay hungry without
anything to eat until in the evening when you have to go and
buy another quarter [kg.] of rice.
While many reported difficulties associated with hunger from
taking ARVs, in some cases this hunger contributed to non-
adherence. For example, a 42-year-old mother of four explained
that she sometimes skipped doses to avoid the pain of feeling
hungry:
Sometimes you could have had a bad breakfast, you didn’t
have any lunch, and supper is also not good, and so you
really don’t feel like taking the medicine, so you don’t take it.
Because if you take it, you feel very bad in your stomach,
very, very bad. So, so hungry like never before, and you’re
trembling, and the daylight is not coming soon enough. You
feel shaking, you’re feeling this very bad hunger, you can’t
even sleep.
Some patients not yet on ARVs expressed concern about the
prospect of increased hunger. A 34-year-old mother of four said
her sister-in-law reported being ‘‘hungry most of the time’’ after
starting on HAART. The woman herself was not yet taking ARVs
but her husband was about to start. The prospect of her husband’s
hunger in the absence of adequate food was a significant source of
stress in her life:
I am worried about my husband’s situation and we have
discussed it, which is why today we went to the counselor
together to find out whether they could reduce the quantity
or give us medicine that’s not as strong. Because if my
husband is hungry all the time and there’s no food, then
what happens?
2. Worse ARV side effects
Many participants reported that taking the ARV medications
without sufficient food exacerbated medication side effects. In
addition to increased hunger on ARVs, these reported side effects
included headaches, stomach pain, dizziness, shivers or tremors,
loss of energy, fainting, sweating, and rapid heartbeat. ‘‘When you
are on ARVs, when you take it on an empty stomach, you don’t
feel well,’’ said a 50-year-old widow. ‘‘You feel like you have
ulcers, like pain in the stomach.’’ A young woman who reported
feeling hungry at least twice a week noted: ‘‘Every time I take the
medicine without eating anything, it does me bad, it saps my
energy. So I struggle to make sure before I take my medicine, I
look for something.’’ A 39-year-old married man with three
children reported a wide range of symptoms:
When I take my ARVs when I haven’t eaten or there’s no
food to eat, I feel uncomfortable, and also I’m shivering, and
sweating and might pass out. What I usually do when I don’t
have food is take the medicine and then go cover myself up
in bed. And my heart rate increases.
Similarly, a 34-year-old mother of five, whose husband died of
AIDS in 2002, described the difficulties of taking ARVs without
food:
When I have to take my medication and I have not eaten, I
get stomach aches and I feel like my heart has been
misplaced— plucked out from it’s normal place—and then I
get a runny stomach. And I get diseases or infections that I
didn’t have when I take it [the medication] with food.
Not surprisingly, many also reported the converse: they
experienced no side effects when they took the medications after
having eaten a sufficient amount. For instance, a woman who
suffered from intense hunger, trembling, and insomnia when she
took ARVs without food described the absence of adverse effects
when she took them on a full stomach: ‘‘This medicine, before you
take it if you’re really full, you have had a good breakfast, a good
lunch, and then also had a good supper, then you take them and
there are no side effects.’’
Despite side effects, many participants were strongly motivated
to take their ARVs at the prescribed times even when sufficient
food was not available. For example, a woman who had been in
treatment for four years continued to struggle with the side effects
of taking ARVs without food: ‘‘Most of the time when I swallow
the medicine before I’ve had food, I feel dizzy in my eyes. I also get
pains in my stomach, like slashing pains in my stomach when I
take medicine without food.’’ Despite this, she did everything
possible to ensure that she adhered to her medication regimen:
‘‘When it comes for time to taking medicine, even if don’t have the
food, I must take it, because if I don’t, I will be disorganizing
something within my life system.’’
A 34-year-old woman, who was separated from her husband
and was living with her parents, said the problem of more severe
side effects of ARVs in the absence of food was a frequent topic of
conversation among patients, but that most accepted this downside
because they recognized the benefits:
Food Insecurity and Adherence
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A lot of people are always complaining about having to take the
medication with nothing, when they have not eaten anything.
But since it’s also for helping them, they decide to take it even
when they know it’s going to affect them and make their
stomachs ache, because they don’t have much of a choice.
3. Advice to take ARVs with a balanced diet
Participants reported that before starting on medication they
had heard–through word-of-mouth from family members, friends,
other patients, or counselors– about the need to eat a balanced
diet on ARVs. Some of what they heard made ARV-naı¨ve
participants question whether they would be able to sustain the
regimen or their health. A 24-year-old woman, pregnant with her
second child, said she hoped to start taking ARVs soon, but was
concerned about what would happen if she initiated treatment
without adequate nutritional support:
What I am worried about most is the fact that they say when
you’re on ARVs, you need to drink a lot and eat very well,
but I don’t think I can afford that…They said it’s a very
strong medicine and if you don’t drink a lot and eat a lot,
then your energy is sapped very fast, and you deteriorate
very fast.
As a result of these concerns about perceived nutritional
demands, participants reported that some people who might
otherwise have initiated HAART chose not to. For example, a 30-
year-widow, who worked as a hawker—someone who sells
merchandise door-to-door—said food insecurity could lead
directly to delayed ARV initiation or a decision not to seek
medical care altogether:
Those who are sick fear to come for treatment, because they
know if they come and their CD4 count is low, doctors will
ask them to eat a balanced diet. But then they say they
cannot afford the food and the balanced diet. To afford such
food is very expensive. So they think they can’t afford it, and
they don’t even come for treatment. Since taking ARVs
according to what they’ve heard necessitates you to spend
more money on food.
In addition to delaying HAART initiation, some individuals
stopped taking their ARVs altogether when they thought that they
could not follow the advice of health care providers to eat a
balanced diet. A widowed mother of three, aged 35 years, reported
that a friend had decided to stop taking her ARVs because she
could not sustain the nutritional demands of ARVs:
She called me on Friday and said she can’t handle what comes
with the medicine, it’s draining her. According to what they are
telling us here about positive living, my friend feels that she will
not be able to do the positive living, since taking the medicine
comes with a change in diet that she cannot afford, since she is
renting a house. So according to her budget, she feels that
stopping the medication would be the best thing.
4. Competing demands
Another theme expressed by participants was the need to make
the difficult choice between spending limited resources on medical
needs—such as the cost of transportation to clinic or the cost of
additional medications to prevent opportunistic infections—and
spending it on food for themselves and their families. Participants
had to either sacrifice an adequate diet for themselves and their
children to afford transport to clinic or other health-related
expenses, or they had to forego picking up their ARVs in order to
access something to eat. Demands for food and health-related
expenses also competed with other essential needs such as school
fees for children, clothing, and household expenses, compounding
the difficult choices families had to make. Some married women
expressed constraints in their ability to make these economic
decisions because of differences with their husbands, who
sometimes spent money just on themselves or had second families
to support. At the same time, women who were separated,
divorced or widowed often reported having to stretch their
provisions to feed a large extended family, reducing the amount of
funds available for medical needs. These impossible choices caused
significant anxiety for many individuals in our study; in some
cases, they also contributed to ARV non-adherence, treatment
interruptions, and fears about HAART initiation.
A 34-year-old woman reported her regret at having to spend 500
shillings ($0.25) for a boda-boda [motor-scooter taxi] to clinic when
she had nothing at home to eat. ‘‘If I had something to eat at home, I
wouldn’t feel bad, because the 500 is also helping me to come here.’’
A 35-year-old widow said she has missed some appointments
with the doctor because food costs for her and her three children
absorbed the money she needed to pay for transportation to the
clinic. ‘‘What happens is that all the money you get you have to
eat, because you buy water, you buy everything,’’ she said. ‘‘By the
time it comes to the clinic, you don’t have the money.’’ She added,
however, that she always found a way to come when it was time to
pick up her monthly supply of medication no matter what her food
situation, although she recognized that travel to clinic entailed
significant opportunity costs:
Sometimes, when I am about to go back home and I have
not left anything in the house to eat, I ask myself when I get
back home, what will I eat? That’s when I feel I have wasted
time by coming to the clinic. But then if I didn’t come to the
clinic, I wouldn’t be able to get the medicine.
Participants expressed considerable anxiety over having to make
such difficult choices. A 32-year-old married mother of five
reported once missing weeks of medication because she didn’t
have the money for both clinic-related expenses and food for her
children:
Sometimes there is stress between my medical needs and my
food needs, because I have to spend a lot on food, but for
medication things I must spend on them, and I find I am
spending a lot on food, and it stresses me. I spend on
transport, but also the multi-vitamins, I have to supplement
them because they give us just a little.
Individuals also often compromised the quality of their diet to
afford medical expenditures. As a result, ARVs increased food
insecurity in the short term for some participants when limited
resources were spent on medical care instead of food.
5. Working for food
Many participants reported that their efforts to access food—
whether through farming for long days in the fields or spending
Food Insecurity and Adherence
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hours seeking paid work to buy something to eat— was a barrier to
ARV adherence. For example, the 30-year-old hawker who had
been on ARVs for four years described how working for food
could interfere with taking doses as prescribed:
The problem I see is that once in a while I forget to take my
medicine at the allocated time…I have to work for food and
thus by the time it comes for taking my medicine I am
maybe too busy with work and I have forgotten about my
medicine…Sometimes you wake up and don’t have posho in
the house to make porridge, and where you have to buy it
from is very far and you don’t have the money, but by the
time you get the money and get the posho, it’s late.
A 57-year-old widow, who earned money selling food and bricks,
said she missed her morning dose on days when she could not find
food. ‘‘Not taking my doses for morning, it happens about twice a
week, and I’m looking for food during that time,’’ she said. ‘‘So
that by the time it comes to 7 pm [time for her night dose] I have
found food, so I am able to take my dose.’’
A number of participants reported having been told not to take
their ARVs if they missed their appointed dose time by an hour or
two. As a result, some said they missed doses because by the time
they could stop working or take a break in their search for food to
eat, they were already more than an hour or two late. A 40-year-
old father of five and farmer whose wife also had HIV said that he
never missed his night dose, but added:
For the morning dose, sometimes I’ve gotten a small job,
and while I’m working, I realize it’s an hour late or an hour
and a half late. And we are sensitized that we shouldn’t take
our medication past a certain time. So I miss that dose
maybe twice a month.
A 38-year-old farmer and food seller not yet on ARVs expressed
concern that he’d be too busy working all day to have time to eat
and drink the amount of food and liquid required with ARVs. ‘‘I
find myself worrying about what would happen to my health if I
did not take the medicine for a whole day as prescribed, since I
have to go to work and as such cannot eat and drink as much as
prescribed.’’
Food insecurity and food supplementation
None of the participants reported receiving any supplemental
food provisions at the time of the interview, although one
mentioned having received such assistance in the past.
As a result of the strong link between food insecurity and non-
adherence, participants emphasized the importance of food
supplementation as part of comprehensive HIV/AIDS care. As
explained by the 57-year-old widow:
If they could distribute a little maize flour with the medicine,
so that the person has something to take their medicine with,
it would be much easier. Most of people who are on ARVs
are not able to look after themselves or buy food, so most of
them come when they are almost at death point, so what
they do is start them on ARVs when they don’t have food…,
and the ARVs kill them because they have no food…But if
they came and got posho alongside ARVs, maybe they’d
have something to drink or eat when they start their
medication.
This participant added that once participants have been on ARVs
for some time, the food support could stop because ‘‘ these people
have already regained energy to start supporting themselves.’’
Discussion
This study is the first to our knowledge to investigate the
potential mechanisms through which food insecurity interferes
with ARV medication-taking behavior. We found that food
insecurity and hunger not only interfere with day-to-day
adherence but that fears about hunger and food insecurity may
also cause people to delay initiating or to discontinue ARV
therapy. Preventing hunger and malnutrition are important goals
in their own right and should comprise a critical component of
comprehensive health care for HIV-infected patients. Since food
insecurity may be contributing to delayed ARV initiation,
incomplete adherence, and ARV treatment discontinuation, food
and nutrition interventions may be an important adjunct to the
substantial investment in ARV programs in resource-limited
setting.
We found five mechanisms through which food insecurity
impacted ARV adherence: increased hunger with ARVs, worse
ARV side effects in the absence of food, counseling on the need to
take ARVs with food, competing demands between food costs and
health care expenses, and forgetting or being unable to take ARV
doses while working for or searching for food. Several of these
mechanisms have been reported in other studies from sub-Saharan
Africa [17,30,31].
While the mechanisms for how food insecurity impacted
adherence were generally similar among women and men, women
were at times less favored in terms of household food distribution.
In addition, women—especially those who were widowed or
otherwise on their own–often reported being solely responsible for
feeding children and other family members. As a result, the
impacts of food insecurity on treatment non-adherence were more
salient among women. Gender disparities in the experience and
health consequences of food insecurity have also been reported in
other settings in sub-Saharan Africa [32,33]. Taken together, these
findings highlight the strong linkages between food insecurity,
gender inequality and worse health outcomes and suggest that
gender inequality and discrimination should be critical targets for
HIV/AIDS programming.
Despite the substantial obstacles to ARV adherence, motivation
to adhere was extremely high in our study, consistent with
previous studies. [7,12,34] However, people living with HIV/
AIDS may not be able to maintain high levels of adherence over
the long-term in the face of such obstacles as experiencing
intractable hunger on HAART, or having to choose between
feeding their families and paying for health-related expenses.
Moreover, treatment options are limited in many resource-
constrained settings; if resistance to first-line drugs develops
because of poor adherence, the negative consequences are more
significant than in countries with access to a broader range of
medications. Limited treatment options also makes it harder to
address ARV side effects related to food insecurity, since
alternative regimens with different side effect profiles are less
readily available.
In addition to the negative consequences of food insecurity on
day-to-day ARV adherence, our study suggests that food insecurity
is a risk factor for ARV treatment interruptions and discontinu-
ation, both which have been shown to be associated with virologic
failure, worse clinical outcomes and mortality. [35,36,37]
Moreover, early ARV initiation has been associated with
decreased mortality [38,39], and our data also show that food
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insecurity is a risk factor for delayed treatment initiation. Previous
data has directly linked food insecurity with incomplete HIV RNA
suppression and mortality even when controlling for effects of
adherence [40,41]. It is possible that these associations between
food insecurity and poor clinical outcomes are mediated in part
through impacts of food insecurity on delayed HAART initiation
and treatment discontinuation, although more studies are needed
to assess this possibility.
The negative impacts of food insecurity on ARV adherence,
treatment continuation, HIV RNA suppression, and mortality
argue for the need to incorporate food supplementation and
sustainable food production strategies as essential components of
emerging ARV treatment programs. Nutritional supplementation
can directly improve both ARV adherence and retention in care.
In an ecological analysis of programmatic factors associated with
loss to follow-up in eight countries in sub-Saharan Africa with over
100,000 individuals, Nash et al. [42] found that programs that
offered nutritional support had substantially lower rates of loss-to-
follow-up compared with programs that did not. Similarly, in a
pilot intervention study in Zambia, individuals receiving food
supplementation with HAART achieved significantly higher ARV
adherence than individuals not receiving food supplementation
[43].
Many local organizations in Uganda have recognized that
adequate food and nutrition are critical to an effective response to
the HIV/AIDS epidemic, and some have initiated programs to
improve food security among HIV-infected individuals. [44] The
AIDS Support Organization (TASO) is the largest non-govern-
mental organization (NGO) providing AIDS prevention and care
services in Uganda and has been collaborating with other NGOs
to expand nutritional support to PLWA. There is also a food
supplementation program for severely malnourished patients
hospitalized on the medical wards at Mbarara University of
Science and Technology.
In addition to basic health training and direct food supplemen-
tation, other interventions that are being scaled up by local NGOs
to improve the food security of PLWA include income generation
activities through small enterprises, home and community
gardening activities, and support for animal husbandry and crop
production. [44]
Limitations
There were several limitations to our study. We did not
interview individuals who were not yet linked to care nor
individuals who were lost to follow-up; it is possible that food
insecurity poses an even greater barrier to HIV care for members
of these two groups and that our data therefore understate the
actual impact of food insecurity on ARV treatment outcomes.
Since interviews were conducted among individuals attending
clinic and consenting to study procedures, the high levels of
adherence reported by participants may be an overestimate of
actual ARV adherence in this setting. In addition, the majority of
participants interviewed were from rural Uganda, with only a few
participants from an urban clinic in Kampala. We were therefore
unable to draw significant distinctions between urban and rural
areas in the mechanisms through which food insecurity may
interact with adherence. We chose not to carry out focus group
discussions because of confidentiality concerns and, especially, the
sensitive nature of the subject matter discussed. Due to time
constraints, no participant observation was conducted . Future
studies on this topic would benefit from more diverse qualitative
techniques to help triangulate the findings.
Conclusion
In this qualitative study from Uganda, we found that many
participants suffered from daily hunger, and that food insecurity
contributed to ARV non-adherence, delayed HAART initiation,
and treatment discontinuation. Freedom from hunger is a basic
human right and warrants immediate attention in its own right.
The link between food insecurity and poor ARV outcomes further
heightens the importance of addressing food insecurity as part of
comprehensive care among HIV-infected individuals worldwide.
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